Anavex Life Sciences Corp. (AVXL)
3.56
-0.24
(-6.32%)
USD |
NASDAQ |
Dec 31, 16:00
3.56
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences Free Cash Flow: -39.04M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Vanda Pharmaceuticals, Inc. | -82.95M |
| CorMedix, Inc. | 74.42M |
| Verastem, Inc. | -140.93M |
| ADMA Biologics, Inc. | 40.61M |
| Aldeyra Therapeutics, Inc. | -40.08M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -8.604M |
| Cash from Financing (Quarterly) | 10.02M |
| Free Cash Flow Per Share (Quarterly) | -0.1002 |
| Free Cash Flow to Equity (Quarterly) | -8.604M |
| Free Cash Flow to Firm (Quarterly) | -8.604M |
| Free Cash Flow Yield | -12.86% |